Severe vitamin D deficiency in a patient treated for hepatitis B with tenofovir

International Journal of STD and AIDS

Volumn 23, Issue 1, 2012, Pages 59-60

  Kumar, N ^a   Bower, M ^a   Nelson, M ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Hepatitis B; Hypophosphataemia; Tenofovir; Vitamin D

Indexed keywords

ALKALINE PHOSPHATASE; PARATHYROID HORMONE; PHOSPHATE; TENOFOVIR; VITAMIN D;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CASE REPORT; CHEMICAL ANALYSIS; DISEASE SEVERITY; DRUG MONITORING; DRUG WITHDRAWAL; FANCONI RENOTUBULAR SYNDROME; HEPATITIS B; HUMAN; HYPOPHOSPHATEMIA; LETHARGY; LOW BACK PAIN; MALE; MYALGIA; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SUBSTITUTION THERAPY; THERAPY DELAY; VITAMIN D DEFICIENCY;

ADENINE; HEPATITIS B; HUMANS; HYPOPHOSPHATEMIA; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE INHIBITORS; VITAMIN D DEFICIENCY;

EID: 84857466491     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009502     Document Type: Article

References (13)

1. Brook MG, Gilson R, Wilkins E, BHIVA Hepatitis Coinfection Guidelines Committee. British HIV Association guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis B virus infection. HIV Med 2005;6(Suppl 2):84-95
2. Tan LK, Gilleece Y, Mandalia S, et al. Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir. J Viral Hepat 2009;16:471-78
3. Mathew G, Knaus SJ. Acquired Fanconi's syndrome associated with tenofovir therapy. J Gen Intern Med 2006;21:C3-5
4. Perrot S, Aslangul E, Szwebel T, et al. Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient. J Clin Rheumatol 2009;15:72-74
5. Parsonage MJ, Wilkins EG, Snowden N, et al. The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. HIV Med 2005;6:341-46
6. Earle KE, Seneviratne T, Shaker J, Shoback D. Fanconi's syndrome in HIV{thorn} adults: report of three cases and literature review. J Bone Miner Res 2004;19:714-21
7. James CW, Steinhaus MC, Szabo S, Dressier RM. Tenofovir-related nephrotoxicity: case report and review of the literature. Pharmacotherapy 2004;24:415-18
8. Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G. Drug-induced Fanconi's syndrome. Am J Kidney Dis 2003;41:292-309
9. Moe SM. Disorders involving calcium, phosphorus, and magnesium. Prim Care 2008;35:215-37, v-vi
10. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81
11. Fux C, Rauch A, Simcock M, et al. Swiss HIV Cohort Study. Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study. Antiviral Ther 2008;13:1077-82
12. Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007;5:513-20
13. Welz T, Childs K, Ibrahim F, et al. Efavirenz use is associated with severe vitamin D deficiency in a large, ethnically diverse urban UK HIV cohort. 5th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2009). Cape Town, South Africa, 2009: Abstract TUPEB186